This PDF is the current document as it appeared on Public Inspection on 07/18/2014 at 08:45 am.
Department of the Army, DoD.
In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i) and 37 CFR 404.7(b)(1)(i), announcement is made of the intent to grant an exclusive, revocable license to the invention claimed in Invention Disclosure RIID 14-26 entitled “Ricin Immunodiagnostic Assay.” The intended licensee is Defence Science Organisation National Laboratories with its principal place of business at 20 Science Park Drive, Singapore 118230.
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, MD 21702-5012.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For licensing issues, Dr. Paul Mele, Office of Research & Technology Applications, (301) 619-6664. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808; both at telefax (301) 619-5034.End Further Info End Preamble Start Supplemental Information
Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES).Start Signature
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-17112 Filed 7-18-14; 8:45 am]
BILLING CODE 3710-08-P